Lisinopril-Induced Liver Injury: An Unusual Presentation and Literature Review

Lisinopril is an angiotensin converting enzyme inhibitor (ACE-I) that has been on market for more than 25 years. ACE-I are usually well tolerated and rarely have serious or life-threatening side effects. We describe an unusual presentation of fulminant hepatic cholestasis probably secondary to lisin...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Rifaie, Ammar, Khan, Mir Azam, Ali, Amjad, Dube, Asha Kumari, Gleeson, Dermot, Hoeroldt, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350971/
https://www.ncbi.nlm.nih.gov/pubmed/32665926
http://dx.doi.org/10.12890/2020_001600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350971/
https://www.ncbi.nlm.nih.gov/pubmed/32665926
http://dx.doi.org/10.12890/2020_001600

Ejemplares similares